The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.

Rehabil Res Pract · 2012 · PMC3532866 · PMID 23304514

Europe PMC DOI

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

did not reach statistical significanceP = 0.29not close (p > 0.1)

Among the MLC601-treated patients, 21 (70%) achieved functional independence defined as mRS 0–2 by the third month as compared to 17 (57%) in the non-MLC601 group although the difference did not reach statistical significance (OR 1.79; 95% CI 0.62–5.2; P = 0.29) ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.